Sanazole as a sensitizer of hypoxic cells with radical radiation in the treatment of advanced cancer of cervix an Indian experience.
Indian J Cancer
;
2002 Jun; 39(2): 39-44
Article
in English
| IMSEAR
| ID: sea-49287
ABSTRACT
AK-2123, is a nitrotriazole with a potential to sensitize hypoxic tissue to radiation. Cancer of cervix in advanced stages are predominantly treated with radiation. These are the tumours which harbour a large hypoxic core. This is an Indian experience of the multicentric trial. Patients were randomized to control and AK-2123 arm. 49 patients were randomized to each group. Patients received external radiation with telecobalt to a dose of 50 Gy in five weeks. Those in the study arm received 600 mg/m2, on alternate days. The patients were further treated with intracavitory radiation a dose of 20 Gy. The total dose of 70 Gy was achieved. Patients in the study arm had a complete response of 71.43% (35 of 49) while only 21 of 49 (42.86%) responded in the control group. The overall survival at two years was 72.2% for the study group and 32.43% for control. Neuropathy, a drug related toxicity was transient except, in one patient, which has persisted. AK-2123, has shown significant radiation sensitizing potential.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Radiation-Sensitizing Agents
/
Radiotherapy Dosage
/
Triazoles
/
Aged
/
Female
/
Humans
/
Uterine Cervical Neoplasms
/
Survival Rate
/
Adult
/
India
Type of study:
Controlled clinical trial
Country/Region as subject:
Asia
Language:
English
Journal:
Indian J Cancer
Year:
2002
Type:
Article
Similar
MEDLINE
...
LILACS
LIS